More specifically, mutations in NPM1 have been reported in approximately 50% of acute myeloid leukemia (AML) with a normal karyotype and represents a distinct subset of AML according to the World Health Organization classification (2, 3). The gene discussed is NPM1; the disease is acute myeloid leukemia.